Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Gilead Sciences Inc (GILD)

2015-01-30@16:30:28 ET
Primary Sclerosing Cholangitis Therapeutic Pipeline Review H1 2015 Market Research Report at RnRMarketResearch.com (PRW)

2015-01-30@16:18:37 ET
Gilead Sciences (GILD) Showing Bullish Technicals With Support At $99.81 (FBM)

2015-01-30@09:31:00 ET
Critical Alerts For Amazon.com, JetBlue, KB Home, Stratasys and Gilead Sciences Released By InvestorsObserver (PRN)

2015-01-30@05:38:47 ET
GILEAD EXPANDS HEPATITIS C ALLIANCE WITH INDIAN PARTNERS (ABW)

2015-01-30@01:21:55 ET
Gilead Sciences Schedules Release of Fourth Quarter and Full Year 2014 Financial Results (CLM)

2015-01-29@21:15:01 ET
Gilead Sciences Inc.Corporate Event Announcement Notice (WSH)

2015-01-29@16:43:00 ET
Gilead Sciences (GILD) Showing Resistance Near $106.58 (FBM)

2015-01-29@08:45:00 ET
Earnings Forecast Buzz for Fannie Mae, Apple, Yahoo, Alibaba, Gilead Sciences, and Bank of America (PRN)

2015-01-29@05:16:12 ET
Gilead Sciences announces senior management changes (DTM)

2015-01-29@04:48:31 ET
Gilead expands hepatitis C generic licensing agreements to include investigational NS5A inhibitor GS-5816 (ABW)

2015-01-29@03:09:47 ET
GILEAD EXPANDS HEPATITIS C DRUG LICENSING PACTS WITH INDIAN FIRMS (ABW)

2015-01-29@03:03:50 ET
GILEAD EXPANDS HEP C LICENSING PACTS (ABW)

2015-01-29@02:08:44 ET
Gilead Sciences expands hepatitis C generic licensing agreement (DTM)

2015-01-28@21:11:50 ET
Gilead Sciences Inc.Corporate Event Announcement Notice (WSH)

2015-01-28@17:38:21 ET
8-K: GILEAD SCIENCES INC (EDK)

2015-01-28@16:30:06 ET
Gilead Announces Executive Promotions (BIZ)

2015-01-28@16:17:41 ET
Mylan Expands Pact With Gilead For HEP-C Drug (ABW)

2015-01-28@09:38:41 ET
Mylan expands Hepatitis C licensing agreement with Gilead (ABW)

2015-01-28@07:10:31 ET
Gilead Includes Pan-Genotypic Agent in HCV Licensing Deals (ZAX)

2015-01-28@06:34:03 ET
Mylan to include investigational Pan-Genotypic Agent Hepatitis C single tablet under expanded licensing agreement with Gilead (MTO)